April 21st 2021, 3:00pm
In recent years, research in treating small cell lung cancer has broadened, bringing emerging therapies like immunotherapy to the forefront.
April 20th 2021, 6:00pm
Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.
April 14th 2021, 6:00pm
Recent study results demonstrated an possible association between a high BMI and risk of cancer and overall mortality, though patients with obesity and lung cancer, renal cell carcinoma and melanoma were found to have a lower risk of death than patients with the same cancers without obesity.
April 13th 2021, 6:00pm
On Feb. 18, CURE hosted a webinar focused on educating patients on biomarker testing. Here, we highlight key takeaways from our panelists.
April 10th 2021, 3:00pm
Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.
April 7th 2021, 12:00pm
CURE spoke with the LUNGevity Foundation about lung cancer and its treatments, as well as aspects to cancer outside of day-to-day care.
April 1st 2021, 1:00pm
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for March 2021.
March 31st 2021, 6:00pm
The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Although the drug is effective for some patients, experts debate its widespread use.
March 29th 2021, 9:00pm
Previously, treatments for patients with extensive-disease small cell lung cancer were limited with a poor prognosis. Researchers sought to investigate if Opdivo plus Yervoy or Opdivo alone would improve survival.
March 25th 2021, 1:00pm
Here is a list of some recent trials that launched within the cancer space in March.
What I Have Learned Helping Friends Through Health Scares
A Cancer Research Writer Turns His Pain Into Hope For Others
Keytruda Shows Promise for Certain Patients with Cutaneous Squamous Cell Carcinoma
Targeting a Specific Genetic Mutation May Change Treatment Landscape for Non-Small Cell Lung Cancer
